US$ 25.94
pancreatitis with glp 1 GLP-1 Receptor Agonists as Treatments for Type 2 Diabetes Updates in Medicine | GLP-1s
Description
Strength training programs for GLP-1 users
This retrospective, observational study assessed persistence and adherence in patients with type 2 diabetes (T2D) initiating once-weekly or daily injectable glucagon-like peptide-1 receptor agonists (GLP-1 RAs) in US clinical practice
Bundle Features

Learn about Farxiga side effects, from common ones like increased urination to more serious
